4B-MAR, 4C-MAR, and 4F-MAR represent a carefully relevant group of novel psychoactive substances (NPS) within the two-amino-5-aryloxazoline household. They can be synthetic stimulants which have emerged as designer medications, developed as structural analogs in the mother or father compound four-methylaminorex (4-MAR) to bypass existing drug sched